Trials / Sponsors / Compugen Ltd
Compugen Ltd
Industry · 5 registered clinical trials — 2 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | A Clinical Trial to Evaluate the Safety and Efficacy of COM701 in Relapsed Platinum Sensitive Ovarian Cancer Ovarian Cancer, Ovarian Cancer Recurrent | Phase 1 / Phase 2 | 2025-07-21 |
| Recruiting | A Clinical Trial to Assess COM503 in Participants With Advanced Solid Malignancies Neoplasm, Cancer, Malignant Tumors | Phase 1 | 2025-01-07 |
| Completed | COM701 in Combination With BMS-986207 and Nivolumab in Subjects With Advanced Solid Tumors. Endometrial Neoplasms, Ovarian Cancer, Solid Tumor | Phase 1 / Phase 2 | 2020-08-31 |
| Active Not Recruiting | COM902 (A TIGIT Inhibitor) in Subjects With Advanced Malignancies Advanced Cancer, Ovarian Cancer, Lung Cancer | Phase 1 | 2020-03-31 |
| Completed | COM701 (an Inhibitor of PVRIG) in Subjects With Advanced Solid Tumors. Advanced Cancer, Ovarian Cancer, Breast Cancer | Phase 1 | 2018-09-06 |